CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Fourth Annual JMP Securities Healthcare Focus Conference on Tuesday, October 6, 2009, at 9:00 a.m. ET at The New York Palace Hotel.
